Lymphoseek
Phase 3Completed 0 watching 0 views this week📈 Rising
69
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Breast Cancer
Conditions
Breast Cancer, Melanoma
Trial Timeline
Jun 1, 2010 → Apr 1, 2011
NCT ID
NCT01106040About Lymphoseek
Lymphoseek is a phase 3 stage product being developed by Navidea Biopharmaceuticals for Breast Cancer. The current trial status is completed. This product is registered under clinical trial identifier NCT01106040. Target conditions include Breast Cancer, Melanoma.
Hype Score Breakdown
Clinical
27
Activity
18
Company
2
Novelty
9
Community
10
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01106040 | Phase 3 | Completed |
| NCT00911326 | Phase 3 | Terminated |
| NCT00671918 | Phase 3 | Completed |
Competing Products
20 competing products in Breast Cancer